In a mouse model of melanoma, knockdown of the gene encoding TIM‐1 in B cells or treatment with an anti‐TIM‐1 antibody resulted in stronger expression of the type I interferon‐responsive gene signature in B cells. The gene discussed is HAVCR1; the disease is melanoma.